Luigi Mangione, the man accused of killing UnitedHealthCare CEO Brian Thompson, is reportedly earning a positive reputation behind bars. Sources inside the Metropolitan Detention Center in Brooklyn told Page Six that Mangione has been described as a “model prisoner” who mentors others and helps new inmates adjust to life in prison.
Sources said Mangione is well-liked by both inmates and staff and has gone out of his way to make the environment safer and calmer for those around him. One insider told the outlet that Mangione is known for his discipline and helpfulness, saying he’s in the general population and “has been very helpful to other new arrivals to get acclimated. He follows all the rules.”
RELATED STORIES: NYPD Claims Luigi Mangione Had No Insurance with UnitedHealthcare
Reportedly Working with Prison Consultant Craig Rothfeld
Sources added that Mangione has received guidance from prison consultant Craig Rothfeld, who is known for working with high-profile inmates to help them adjust to life behind bars. Rothfeld’s mentorship reportedly helped Mangione maintain a calm, structured approach during his incarceration. According to insiders, Mangione spends much of his time mentoring new inmates, helping them understand facility rules and avoid disciplinary issues. He is said to have built a solid reputation among his peers for staying out of trouble and encouraging others to do the same.
One source told Page Six that Mangione “follows all the rules” and has become a steady influence on younger or newly arrived inmates.
Mangione Facing Federal and State Murder Charges
Despite his calm demeanor in custody, Mangione still faces serious criminal charges. He has pleaded not guilty to both federal and state counts in connection with the alleged murder of UnitedHealthCare CEO Brian Thompson.
The incident reportedly occurred outside of an annual investor conference on December 4, 2024. Authorities said Mangione was arrested five days later in Pennsylvania following a multi-state manhunt. His federal court date is scheduled for December 5, though no trial date has been set.